Avidity Biosciences Inc (RNA)
25.96
-1.17
(-4.31%)
USD |
NASDAQ |
May 10, 16:00
25.96
0.00 (0.00%)
After-Hours: 19:30
Avidity Biosciences Enterprise Value: 1.567B for May 9, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 09, 2024 | 1.567B |
| May 08, 2024 | 1.482B |
| May 07, 2024 | 1.429B |
| May 06, 2024 | 1.504B |
| May 03, 2024 | 1.513B |
| May 02, 2024 | 1.444B |
| May 01, 2024 | 1.461B |
| April 30, 2024 | 1.328B |
| April 29, 2024 | 1.374B |
| April 26, 2024 | 1.347B |
| April 25, 2024 | 1.304B |
| April 24, 2024 | 1.405B |
| April 23, 2024 | 1.409B |
| April 22, 2024 | 1.331B |
| April 19, 2024 | 1.217B |
| April 18, 2024 | 1.241B |
| April 17, 2024 | 1.282B |
| April 16, 2024 | 1.311B |
| April 15, 2024 | 1.311B |
| April 12, 2024 | 1.325B |
| April 11, 2024 | 1.426B |
| April 10, 2024 | 1.449B |
| April 09, 2024 | 1.466B |
| April 08, 2024 | 1.380B |
| April 05, 2024 | 1.368B |
| Date | Value |
|---|---|
| April 04, 2024 | 1.293B |
| April 03, 2024 | 1.528B |
| April 02, 2024 | 1.547B |
| April 01, 2024 | 1.509B |
| March 28, 2024 | 1.439B |
| March 27, 2024 | 1.371B |
| March 26, 2024 | 1.322B |
| March 25, 2024 | 1.253B |
| March 22, 2024 | 1.294B |
| March 21, 2024 | 1.326B |
| March 20, 2024 | 1.337B |
| March 19, 2024 | 1.301B |
| March 18, 2024 | 1.312B |
| March 15, 2024 | 1.351B |
| March 14, 2024 | 1.316B |
| March 13, 2024 | 1.384B |
| March 12, 2024 | 1.213B |
| March 11, 2024 | 1.080B |
| March 08, 2024 | 1.115B |
| March 07, 2024 | 1.001B |
| March 06, 2024 | 1.001B |
| March 05, 2024 | 930.48M |
| March 04, 2024 | 908.16M |
| March 01, 2024 | 1.008B |
| February 29, 2024 | 863.52M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-181.71M
Minimum
Oct 27 2023
1.567B
Maximum
May 09 2024
546.75M
Average
565.74M
Median
Jul 06 2021
Enterprise Value Benchmarks
| Ironwood Pharmaceuticals Inc | 1.660B |
| Codexis Inc | 187.07M |
| Akoya Biosciences Inc | 211.79M |
| DocGo Inc | 305.39M |
| Kineta Inc | 2.008M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -60.44M |
| Revenue (Quarterly) | 2.193M |
| Total Expenses (Quarterly) | 68.94M |
| EPS Diluted (Quarterly) | -0.80 |
| Profit Margin (Quarterly) | -2.76K% |
| Earnings Yield | -11.21% |
| Normalized Earnings Yield | -11.21 |